Vivo Capital, LLC

13F Portfolio Filings

  • Most recent 13F
    Q1 2026
  • Location
    palo alto, CA
  • CIK
    0001674712
  • All SEC filings

Q1 2026 Summary

Quarter
Holdings
VALUE
Top Holdings
Form Type
Date Filed
Filing Id

45

$1.2B
ERAS, PRAX, TERN, TREVI THERAPEUTICS INC
13F-HR
May 15, 2026
000121390026057929

47

$1.55B
TERN, CDTX, PRAX, COGT
13F-HR
Feb 13, 2026
000121390026016236

47

$1.24B
SOLENO THERAPEUTICS INC, VRNA, CDTX, TERN
13F-HR
Nov 14, 2025
000121390025110767

42

$977.11M
SOLENO THERAPEUTICS INC, VRNA, CDTX, GON
13F-HR
Aug 13, 2025
000121390025075901

40

$755.07M
SOLENO THERAPEUTICS INC, VRNA, GON, TREVI THERAPEUTICS INC
13F-HR
May 12, 2025
000121390025041737

40

$892.62M
SOLENO THERAPEUTICS INC, VRNA, GON, TERN
13F-HR
Feb 13, 2025
000121390025013306

43

$1.21B
SOLENO THERAPEUTICS INC, GON, HRMY, VRNA
13F-HR
Nov 13, 2024
000121390024097589

42

$1.08B
SOLENO THERAPEUTICS INC, GON, HRMY, SINOVAC BIOTECH LTD
13F-HR
Aug 14, 2024
000121390024068546

42

$1.27B
SOLENO THERAPEUTICS INC, GON, HRMY, SINOVAC BIOTECH LTD
13F-HR
Apr 22, 2024
000121390024034979

47

$1.22B
SOLENO THERAPEUTICS INC, GRACELL BIOTECHNOLOGIES INC, VRNA, HRMY
13F-HR
Feb 7, 2024
000121390024010646

53

$912.77M
GTH, SOLENO THERAPEUTICS INC, HRMY, VRNA
13F-HR
Nov 8, 2023
000121390023084732

48

$1.45B
SINOVAC BIOTECH LTD, HRMY, VRNA, FL3
13F-HR
Aug 14, 2023
000121390023067000

48

$1.44B
SINOVAC BIOTECH LTD, GTH, VRNA, HRMY
13F-HR
May 15, 2023
000121390023039212

48

$869K
HRMY, TERN, VRDN, ALXO
13F-HR
Feb 13, 2023
000121390023010818

51

$905.81M
HRMY, TIL, VTYX, VRNA
13F-HR
Nov 14, 2022
000121390022072092

49

$995.88M
HRMY, SRRA, TIL, ISEE
13F-HR
Aug 15, 2022
000121390022047557

54

$1.45B
HRMY, NEW FRONTIER HEALTH CORP, TIL, ISEE
13F-HR
May 13, 2022
000121390022026422

55

$1.66B
TIL, HRMY, NEW FRONTIER HEALTH CORP, ISEE
13F-HR
Feb 11, 2022
000121390022006960

60

$2.23B
ALXO, TIL, HRMY, NEW FRONTIER HEALTH CORP
13F-HR
Nov 15, 2021
000121390021059130

59

$2.31B
TIL, ALXO, ASND, AMRSQ
13F-HR
Aug 16, 2021
000121390021042960

63

$2.85B
TIL, ALXO, AMRSQ, ASND
13F-HR
May 17, 2021
000121390021026949

59

$2.24B
ALXO, ASND, HRMY, TARS
13F-HR
Feb 16, 2021
000121390021009490

64

$1.73B
ASND, ALXO, HRMY, NEW FRONTIER HEALTH CORP
13F-HR
Nov 13, 2020
000121390020036943

54

$1.39B
ASND, LEGN, NEW FRONTIER HEALTH CORP, GTH
RESTATEMENT
Nov 13, 2020
000121390020036945

53

$1.1B
ASND, NEW FRONTIER HEALTH CORP, KDMN, ARQT
13F-HR
May 15, 2020
000121390020012587

49

$1.37B
Ascendis Pharma A/S, Aclaris Therapeutics, Inc., Aclaris Therapeutics, Inc., Aclaris Therapeutics, Inc.
RESTATEMENT
Feb 25, 2020
000121390020004679

49

$878.83M
Ascendis Pharma A/S, Aclaris Therapeutics, Inc., Aclaris Therapeutics, Inc., Aclaris Therapeutics, Inc.
13F-HR
Nov 13, 2019
000121390019023217

46

$1.07B
ASND, CRNX, ARWR, TRICIDA INC
13F-HR
Aug 13, 2019
000121390019015546

49

$1B
ASND, CRNX, CDXS, ARWR
13F-HR
May 14, 2019
000161577419007680

45

$783.08M
ASND, CRNX, BIOHAVEN PHARMACTL HLDG CO L, CDXS
13F-HR
Feb 13, 2019
000161577419002398

44

$992.16M
ASND, CRNX, BIOHAVEN PHARMACTL HLDG CO L, CDXS
13F-HR
Nov 13, 2018
000161577418012532

40

$776.07M
ASND, BIOHAVEN PHARMACTL HLDG CO L, KDMN, CDXS
13F-HR
Aug 10, 2018
000161577418007846

34

$705.92M
MNLOUSD, ASND, BIOHAVEN PHARMACTL HLDG CO L, CDXS
13F-HR
May 15, 2018
000121465918003735

30

$466.86M
ASND, BIOHAVEN PHARMACTL HLDG CO L, ACRS, APLS
13F-HR
Feb 9, 2018
000121465918001028

29

$494.81M
BIOHAVEN PHARMACTL HLDG CO L, ACRS, ASND, NABRIVA THERAPEUTICS PLC
13F-HR
Nov 13, 2017
000121465917006608

26

$397.07M
ACRS, Biohaven Pharmaceutical Holding Company Ltd, ASND, 1520476D
13F-HR
Aug 2, 2017
000121465917004735

23

$339.95M
ACRS, ASND, 1520476D, CDXS
13F-HR
May 15, 2017
000121465917003338

25

$303.45M
ACRS, ASND, CDXS, 1520476D
RESTATEMENT
Apr 6, 2017
000121465917002413

22

$320.89M
ACRS, ASND, EIGR, CDXS
13F-HR
Nov 14, 2016
000121465916014565

23

$366.18M
SGNT, ACRS, EIGR, 1520476D
13F-HR
Aug 15, 2016
000121465916013202

24

$398.68M
ACRS, SGNT, BITI, 1520476D
13F-HR
May 16, 2016
000121465916011605
Vivo Capital, Llc 13F Filings